China only approved its first biosimilar drug in 2019, but the market is already looking too crowded for one Big Pharma company. Pfizer has halted its biosimilar programs in China and is selling a biologics facility there to Chinese CDMO giant WuXi Biologics, the company said in a statement Wednesday. The “difficult decision” came after a… Read More »
The company already has over 20 customers in Japan, including several major retail and transport & logistics brands. Tokyo, Japan – November 20, 2020 – Scandit, the leading technology platform for mobile computer vision and augmented reality (AR) solutions for enterprises, today announced that it is expanding into the Japanese market with the establishment of… Read More »
Verdane Capital IX (Verdane) is the major investor in data visualisation reporting firm Dapresy AB and will merge the two companies London, UK, Oslo, Norway, Stockholm, Sweden – 19 February 2020 – Verdane, the Northern European specialist growth equity investor, has acquired Confirmit, the leading global solutions provider for Customer Experience (CX), Employee Experience and… Read More »
Former FDA Commissioner Scott Gottlieb said Monday that Juul Labs’ products should be removed from the market, citing two studies that showed the scope of teen use of its e-cigarettes and flavored pods. “It’s very clear that Juul can’t keep their products out of the hands of kids,” said Gottlieb, a physician, health advocate and Pfizer board… Read More »